Selexipag

Selexipag

Selexipag is a selective non-prostanoid IP prostacyclin receptor agonist.

Systematic Name

2-[4-[(5,6-Diphenylpyrazin-2-Yl)-Propan-2-Ylamino]Butoxy]-N-Methylsulfonylacetamide

Brand Name(S)

Uptravi

Therapeutic Category

PA – hypertension

Suitable Formulations

Solid

Approvals

Developed

Do You Have A Question? Lets Have A Talk

Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.